We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
86 hedge funds and large institutions have $221M invested in Lexicon Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 30 increasing their positions, 31 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
268% more call options, than puts
Call options by funds: $475K | Put options by funds: $129K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.93% less ownership
Funds ownership: 80.35% → 79.42% (-0.93%)
3% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 31
12% less capital invested
Capital invested by funds: $251M → $221M (-$30.3M)
15% less funds holding
Funds holding: 101 → 86 (-15)
71% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 17
Holders
86
Holders Change
-15
Holders Change %
-14.85%
% of All Funds
1.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
30
Reduced
31
Closed
17
Calls
$475K
Puts
$129K
Net Calls
+$346K
Net Calls Change
+$242K
Top Buyers
Top Sellers
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$803K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$546K |
| 3 |
HF
HRT Financial
New York
|
-$506K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$447K |
| 5 |
Walleye Capital
New York
|
-$420K |
